Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States,

Abdul Mannan Khan Minhas1, Muhammad Umer Awan2, Munis Raza3

  • 1Department of Medicine, Forrest General Hospital, Hattiesburg, MS.

Insights

Percutaneous coronary intervention (PCI) in young adults decreased, but in-hospital mortality and comorbidities rose. Women experienced higher mortality rates than men, highlighting disparities in PCI outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Public Health

Background:

  • Percutaneous coronary intervention (PCI) in young adults (18-45 years) is understudied, despite potential clinical and economic implications.
  • Understanding trends in PCI utilization, outcomes, and costs in this demographic is crucial for healthcare planning.

Purpose of the Study:

  • To analyze trends in PCI volume, in-hospital mortality, length of stay, and healthcare expenditure among US adults aged 18-45 from 2004 to 2018.
  • To identify factors associated with in-hospital mortality and assess demographic disparities in PCI outcomes.

Main Methods:

  • Utilized the National Inpatient Sample database (2004-2018) for weighted analysis of national estimates.
  • Identified 558,611 PCI cases in adults aged 18-45.
  • Analyzed trends in PCI volume, mortality, length of stay, costs, and comorbidities, including risk-adjusted mortality.

Main Results:

  • Annual PCI volume decreased significantly (41.6 to 21.9 per 100,000), primarily in non-myocardial infarction cases.
  • In-hospital mortality increased (crude and risk-adjusted) from 2004-2018, with higher rates in women (1.12% vs 0.78%).
  • Prevalence of cardiometabolic comorbidities, smoking, and drug abuse increased; costs rose to $24,173 (inflation-adjusted).

Conclusions:

  • Despite reduced PCI volumes in young adults, there was an increase in mortality and clinical comorbidities.
  • Significant demographic disparities exist, with women facing higher in-hospital mortality.
  • The findings underscore the need for targeted interventions and further research into PCI outcomes for younger populations.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
48
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
68